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2-APB-potentiated channels amplify CatSper-induced Ca2+ signals
in human sperm
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*Medical School, University of Birmingham, Birmingham B15 2TT, U.K., †Birmingham Women’s Hospital, Birmingham B15 2TG, U.K., ‡School of Biosciences, University of
Birmingham, Birmingham B15 2TT, U.K., and §Division of Cardiovascular Medicine, Medical Research Institute, Ninewells Hospital University of Dundee, Dundee DD1 9SY,
Scotland, U.K.
Ca2 + i signalling is pivotal to sperm function. Progesterone, the
best-characterized agonist of human sperm Ca2 + i signalling,
stimulates a biphasic [Ca2 + ]i rise, comprising a transient and
subsequent sustained phase. In accordance with recent reports
that progesterone directly activates CatSper, the [Ca2 + ]i transient
was detectable in the anterior flagellum (where CatSper is
expressed) 1–2 s before responses in the head and neck. Pre-
treatment with 5 μM 2-APB (2-aminoethoxydiphenyl borate),
which enhances activity of store-operated channel proteins
(Orai) by facilitating interaction with their activator [STIM
(stromal interaction molecule)] ‘amplified’ progesterone-induced
[Ca2 + ]i transients at the sperm neck/midpiece without modifying
kinetics. The flagellar [Ca2 + ]i response was unchanged. 2-APB
(5 μM) also enhanced the sustained response in the midpiece,
possibly reflecting mitochondrial Ca2 + accumulation downstream
of the potentiated [Ca2 + ]i transient. Pre-treatment with 50–
100 μM 2-APB failed to potentiate the transient and suppressed
sustained [Ca2 + ]i elevation. When applied during the [Ca2 + ]i
plateau, 50–100 μM 2-APB caused a transient fall in [Ca2 + ]i,
which then recovered despite the continued presence of 2-
APB. Loperamide (a chemically different store-operated channel
agonist) enhanced the progesterone-induced [Ca2 + ]i signal and
potentiated progesterone-induced hyperactivated motility. Neither
2-APB nor loperamide raised pHi (which would activate CatSper)
and both compounds inhibited CatSper currents. STIM and Orai
were detected and localized primarily to the neck/midpiece and
acrosome where Ca2 + stores are present and the effects of 2-APB
are focussed, but store-operated currents could not be detected in
human sperm. We propose that 2-APB-sensitive channels amplify
[Ca2 + ]i elevation induced by progesterone (and other CatSper
agonists), amplifying, propagating and providing spatio-temporal
complexity in [Ca2 + ]i signals of human sperm.
Key words: calcium, CatSper, hyperactivation, progesterone,
sperm, store-operated channel.
INTRODUCTION
Within the female tract, mammalian sperm receive essential ‘cues’
from the tract itself and from the cumulus–oocyte complex. These
cues regulate a variety of the sperm’s activities through Ca2 +
signalling [1]. Although [Ca2 + ]i signals in sperm are diverse and
often complex [1], patch-clamp studies have, so far, detected only
a handful of channels, and only one Ca2 + -permeable channel,
the pHi-regulated channel CatSper, which is expressed only
in the sperm flagellum [2,3]. CatSper is sensitive to pHi, Em
(membrane potential) and a range of small organic molecules,
such that it can be viewed as a ‘polymodal chemosensor’[4].
Thus sperm Ca2 + signals, even those in the head, may be mediated
primarily or completely through CatSper [4,5].
Progesterone, which is present at high micromolar levels in
the cumulus and at low concentrations throughout the tract, is
by far the best characterized natural agonist of human sperm
activity, modulating the crucial functions of motility and acrosome
reaction [6]. These effects are exerted through Ca2 + influx,
which generates a [Ca2 + ]i transient followed by a prolonged
plateau [7,8]. This [Ca2 + ]i signal is correlated with fertility [9,10],
illustrating the importance of progesterone [and/or the signalling
process(es) that it activates] in sperm function. Consistent with
a central role for CatSper channels in sperm [Ca2 + ]i signalling,
it has recently been shown that progesterone activates CatSper
in human sperm [11,12]. A key question, therefore, is whether
this CatSper-mediated Ca2 + entry is sufficient to explain fully
progesterone-induced Ca2 + signalling in sperm and its crucial
effects on sperm function.
Blackmore [13] and, more recently, Park et al. [14]
proposed that CCE (capacitative Ca2 + entry), the process by
which mobilization of stored Ca2 + induces Ca2 + -influx at the
plasmalemma [15], may contribute to the action of progesterone.
CCE requires both a membrane Ca2 + -permeable channel and
a mechanism by which [Ca2 + ] in the store is monitored. In
somatic cells, the protein STIM (stromal interaction molecule)
situated in the endoplasmic reticulum membrane detects luminal
[Ca2 + ]. Upon store mobilization, STIM redistributes into ‘puncta’
adjacent to the plasma membrane, where it activates Ca2 + -
permeable SOCs (store-operated channels) [16]. SOC proteins
include the Orai family (also named CRACM) and possibly
members of the TRPC (transient receptor potential canonical)
family, which may form heterologous tetramers with Orai subunits
[17–19].
Abbreviations used: 2-APB, 2-aminoethoxydiphenyl borate; BCECF, 2′,7′-bis-(2-carboxyethyl)-5(6)-carboxyfluorescein; CCD, charge-coupled-device;
CCE, capacitative Ca2+ entry; DVF, divalent-free; GFP, green fluorescent protein; HEK, human embryonic kidney; IP3R, inositol trisphosphate receptor;
OGB, Oregon Green BAPTA; PHN, posterior head and neck; sEBSS, supplemented Earle’s balanced salt solution; SERCA, sarcoplasmic/endoplasmic
reticulum Ca2+ -ATPase; SOC, store-operated channel; STIM, stromal interaction molecule; TRPC, transient receptor potential canonical; TRPV3, transient
receptor potential vanilloid 3.
1 To whom correspondence should be addressed (email s.j.publicover@bham.ac.uk).
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In cells transfected with STIM, low doses (<10 μM) of
2-APB (2-aminoethoxydiphenyl borate) [20] potentiate CCE
by promoting the interaction of STIM with SOCs and
also regulating gating of the channel [21–23]. 2-APB can also
activate some STIM–Orai complexes without store mobilization
[24–26]. At higher concentrations (50 μM), the drug inhibits
CCE, although this effect is dependent on the isoform of
Orai expressed [24,25,27,28]. 2-APB can affect other aspects
of Ca2 + signalling [29,30] but these non-target effects occur
at high doses {100 μM; IC50 for inhibition of microsomal
IP3Rs (inositol trisphosphate receptors) = 220–1000 μM and
IC50 for SERCA (sarcoplasmic/endoplasmic reticulum Ca2 + -
ATPase) = 375–725 μM depending on isoform [31,32]}. In the
present study we report that Ca2 + signalling activated by
progesterone is amplified by low concentrations of 2-APB and by
loperamide, another modulator of these channels. These effects
are not exerted through CatSper and are localized to the sperm
neck and midpiece where Ca2 + stores are present and where we
detect expression of STIM and Orai proteins.
EXPERIMENTAL
Saline solutions
sEBSS (supplemented Earle’s balanced salt solution)
contained 1.0167 mM NaH2PO4, 5.4 mM KCl, 0.811 mM
MgSO4·7H2O, 5.5 mM C6H12O6, 2.5 mM C3H3NaO3,
19.0 mM CH3CH(OH)COONa, 1.8 mM CaCl2·2H2O, 25.0 mM
NaHCO3, 118.4 mM NaCl and 15 mM Hepes (pH 7.35, 285–
295 mOsm), supplemented with 0.3% fatty-acid-free BSA. In
non-capacitating medium (bicarbonate-free sEBSS), NaHCO3
was omitted and osmotic strength was maintained by adjusting
NaCl. Low Ca2 + EGTA-buffered sEBSS (≈3×10− 7 M Ca2 + )
contained 5 mM Ca2 + and 6 mM EGTA.
Preparation and capacitation of spermatozoa
Donors were recruited in accordance with the Human and
Embryology Authority Code of Practice (Version 7) and gave
informed consent (University of Birmingham Life and Health
Sciences ERC 07-009 and 08/S1402/6 from the Tayside
Committee of Medical Research Ethics B). Cells were harvested
by direct swim-up as described previously [33] and adjusted to
6×106 cells/ml. Aliquots of 200 μl were left to capacitate for
5–6 h.
For Western blotting analysis and immunoprecipitation, cells
were separated from seminal plasma by densitometry using a two-
layer Percoll gradient (40 and 80%) as described previously [34]
and were capacitated as described above.
Single-cell imaging of [Ca2+ ]i
Loading of cells with OGB {Oregon Green BAPTA [1,2-bis-(o-
aminophenoxy)ethane-N,N,N ′,N ′-tetra-acetic acid] 1} and time-
lapse fluorescence imaging was as described previously [33]. All
experiments were performed at 25 +− 0.5 ◦C in a continuous flow
of medium {sEBSS or EGTA-buffered saline ([Ca2 + ]o≈3×10− 7
M)}. Images were captured at 0.1 Hz (except where stated
otherwise) using a 40× oil-immersion objective and a Q Imaging
Rolera-XR cooled CCD (charge-coupled-device) camera or a
Andor Ixon 897 EMCCD (electron-multiplying CCD) camera
controlled by iQ software (Andor Technology).
Analysis of images, background correction and normalization
of data was performed as described previously [33]. Unless stated
otherwise, the region of interest was drawn around the PHN
(posterior head and neck) region of each cell. Raw intensity values
were imported into Microsoft Excel and normalized using the
equation:
F = [(F − Frest)/Frest] × 100%
where F is the percentage change in fluorescence intensity at
time t, F is fluorescence intensity at time t and Frest is the mean of
10 determinations of F during the control period. To compare
the responses between experiments, we calculated Fmean, the
mean F of all the cells (n = 50–200) in the experiment.
The amplitude of the progesterone-induced [Ca2 + ]i transient
was calculated from the three points spanning the peak of
the Fmean trace. Plateau amplitude was calculated from three
consecutive points 4 min after application of progesterone. In
experiments involving pre-treatment with 2-APB or loperamide
transient peak and plateau values were corrected for F
(or Fmean) immediately before progesterone application
(Supplementary Figure S1 at http://www.BiochemJ.org/bj/448/
bj4480189add.htm).
Population fluorimetry
[Ca2 + ]i assessment was as described previously [35]. For
assessment of pHi, 2 ml aliquots were labelled with 1 μM
BCECF-AM [2′,7′-bis-(2-carboxyethyl)-5(6)-carboxyfluorescein
acetoxymethyl ester; 30 min, 37 ◦C, 5%CO2], centrifuged (300 g,
5 min) then resuspended in sEBSS. Sampling rate was 12.5 Hz
using excitation 440/495 nm and emission 535 nm. pHi was
calibrated similarly to [36].
Patch-clamp
Whole-cell currents were evoked by 1 s voltage ramps from
− 80 mV to + 80 mV from a holding potential of 0 mV (before
correction for junction potential). DVF (divalent-free) medium
for recording CatSper currents contained 140 mM caesium
methanesulfonate, 40 mM Hepes and 1 mM EGTA, pH 7.4, as
described by Lishko et al. [11]. The pipette saline contained
130 mM caesium methanesulfonate, 70 mM Hepes, 3 mM EGTA,
2 mM EDTA and 0.5 mM Tris/HCl, pH 7.4.
Detection of proteins by Western blotting
Sperm proteins were extracted using RIPA buffer [150 mM NaCl,
20 mM Tris/HCl, pH 7.4, 2 mM DTT (dithiothreitol) and 1%
Triton X-100] supplemented with 0.5% SDS and CompleteTM
protease inhibitor cocktail (Roche). Following brief sonication
(MSE Soniprep 150, 20 s at 20 ◦C), samples were incubated for
30 min at 4 ◦C then centrifuged at 18000 g for 15 min at 4 ◦C to
remove any insoluble material. Aliquots of supernatant (20 μl)
were kept for SDS/PAGE.
Electrophoresis was performed as described previously [37].
Proteins were separated by SDS/PAGE using 10% gels for STIM
and 15% gels for Orai. Membranes were incubated overnight
(4 ◦C) with the respective anti-Orai (1:250 dilution, ProSci; or
1:200 dilution, Sigma) or anti-STIM (1:1000 dilution, ProSci)
antibodies. Where possible, pre-adsorption of antibodies with
their corresponding antigenic peptides was carried out to assess
the specificity of the detection. Antibody (1 μg) was pre-adsorbed
with excess (1 μg) peptide for 1 h at room temperature (20 ◦C).
Incubations with peptide-pre-adsorbed and non-pre-adsorbed
antibodies were performed in parallel.
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Immunoprecipitation
Percoll-washed spermatozoa (at least 200 × 106 cells per
condition) were solubilized using RIPA buffer supplemented
with 0.5% SDS and CompleteTM protease inhibitor cocktail.
Following brief sonication, samples were incubated at 4 ◦C
for 1 h then diluted 10-fold with RIPA buffer to avoid SDS
interference with immunoprecipitation procedures. Samples
were centrifuged at 18000 g (15 min, 4 ◦C) to remove insoluble
material. A pre-clearing step involved incubation with 30 μl of
a pre-washed Protein G plus/Protein A–agarose beads (33%
slurry suspension; Calbiochem) for 30 min at 4 ◦C followed by
a centrifugation at 2500 g (5 min). Pre-cleared sperm lysate was
further centrifuged (13000 g, 10 min) and the supernatant was
transferred to a fresh microfuge tube and kept at 4 ◦C.
Protein G plus/Protein A–agarose beads (20 μl) (33% slurry
suspension) were incubated overnight with 1 μg of antibody in
750 μl of RIPA buffer then washed three times with RIPA buffer
and the remaining supernatant was aspirated away. Pre-cleared
sperm lysate was then added to the antibody-coated beads and
incubated for 90 min (4 ◦C). The immunocomplex was pelleted
by centrifugation (2500 g, 5 min) and washed three times with
1 ml of immunoprecipitation buffer followed by twice with 1 ml
of PBS. The immunoprecipitated proteins were resuspended in
20 μl of 1× SDS sample buffer, incubated at 70 ◦C for 10 min
and submitted to SDS/PAGE as described above.
Detection of Orai and STIM by immunofluorescence
Percoll-washed spermatozoa (2 × 105 cells) were prepared for
immunocytochemistry as described in [35]. Slides were incubated
overnight (4 ◦C) with anti-Orai (1:10 dilution, ProSci and
Sigma) and anti-STIM antibodies (1:25 dilution, ProSci). Where
possible, pre-adsorption of Orai and STIM antibodies with their
corresponding antigenic peptides was carried out (as described
above) to assess specificity. Experiments using peptide-pre-
adsorbed and non-pre-adsorbed antibodies were performed in
parallel. Slides were then prepared as described in [35].
Assessment of distribution of STIM
After capacitation as described above or immediately after swim-
up into non-capacitating sEBSS, 200 μl aliquots of spermatozoa
were exposed to bis-phenol (15 μM). After 12 min, cells were
centrifuged (2000 g, 5 min) then fixed in 4% formaldehyde
(6 min). Cells were re-centrifuged, resuspended in PBS, smeared
on poly-L-lysine-coated slides and air-dried. Permeabilization,
antibody staining and processing for assessment of acrosome
reaction were as described above.
Statistical analysis
Values given in the text are means +− S.E.M. For most comparisons
we used Fmean values obtained from parallel control and pre-
treatment experiments such that ‘n’ refers to the number of pairs
of experiments. Each Fmean value was the average of 50–200
normalized single-cell responses. Microsoft Excel was used to
calculate correlation coefficients and perform paired or unpaired
t tests and χ 2 tests as appropriate. Where n is the number of cells
this is stated.
RESULTS AND DISCUSSION
Effect of 2-APB on resting [Ca2+ ]i in human sperm
Treatment of sperm with 5 μM 2-APB increased [Ca2 + ]i in
∼75% of cells, inducing a plateau or a series of transients
Figure 1 2-APB elevates resting [Ca2+ ]i
(a) 2-APB (5 μM; arrow) causes a sustained increase in the PHN [Ca2 + ]i of a subset of cells. The
traces show ten individual cell responses and F mean (-) for all 87 cells in the experiment.
(b and c) 2-APB-induced [Ca2 + ]i elevation is dose-independent. (b) Increase in F mean 3 min
after application of 2-APB. Results are means +− S.E.M. for sets of four experiments in each of
which aliquots from the sample were tested with each of the three concentrations of 2-APB.
(c) Dose-dependence of 2-APB-induced [Ca2 + ]i increment in fura-2-loaded cell populations
(means +− S.E.M. for 6–17 experiments). (d) 2-APB-induced rise in [Ca2 + ]i is reversed in
low-Ca2 + saline. Cells were superfused with EGTA-buffered saline (shown by shading) then
exposed to 5 μM 2-APB (arrow). 2-APB-induced [Ca2 + ]i increase was abolished and in many
cells 2-APB induced a further fall in [Ca2 + ]i . Traces show six individual cell responses and
F mean (-) for all 85 cells in the experiment.
(Figure 1a). Within ∼100 s, Fmean stabilized at an increased
level and at 3 min was 15.6 +− 3.7% at the PHN and 8.5 +− 2.9%
at the midpiece (P = 0.008; paired t test, n = 11 experiments).
Higher doses of 2-APB (up to 100 μM) had similar effects to
5 μM (Figure 1b; P > 0.5; paired t test, n = 4) and the same dose-
insensitivity was observed when [Ca2 + ]i was measured in fura-2-
loaded cell populations (Figure 1c). When cells were prepared
under non-capacitating conditions (BSA and bicarbonate-free
sEBSS but containing Ca2 + ), the increase in resting [Ca2 + ]i
induced by 5 μM 2-APB was significantly smaller (PHN Fmean
at 3 min = 7.4 +− 2.0%; n = 7; P = 0.03).
Superfusion of capacitated cells with EGTA-buffered medium
(∼3 × 10− 7M Ca2 + ) for 3 min prior to the application of 5 μM
2-APB caused a sustained fall in [Ca2 + ]i and abolished the
stimulatory effect of 2-APB, showing that the drug was not
releasing stored Ca2 + . In addition, in more than 20% of cells
(22 +− 3%; n = 5) application of 2-APB induced a further [Ca2 + ]i
decrease, which was visible as a fall in Fmean (Figure 1d). Similar
effects were seen with 50 and 100 μM 2-APB. This reversal of
the effect of 2-APB upon buffering of [Ca2 + ]o shows that it acts
by increasing plasma membrane Ca2 + permeability.
2-APB might increase membrane Ca2 + flux by activating
CatSper either directly [4] or by cytoplasmic alkalinization [11].
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Figure 2 2-APB does not enhance CatSper currents
(a) Monovalent CatSper currents recorded before (black trace) and after (grey trace) application
of 5 μM (left-hand panel) and 100 μM (right-hand panel) 2-APB. Horizontal (near zero) traces
show currents in divalent cation-containing saline. (b) Time course of CatSper current block by
100 μM 2-APB. Cell conductance was calculated from the slope between + 50 and + 60 mV.
Grey shading shows superfusion with DVF saline, arrow shows application of 2-APB. (c) 2-APB
does not raise pHi. 2-APB at 5 and 15 μM was added at the first and second arrows respectively.
4-Aminopyridine (2 mM; 4-AP; positive control) caused an immediate rise in pHi. (d) Mean
pHi change ( +− S.E.M.) in response to 5 μM (n = 6), 15 μM (n = 3) and 50 μM (n = 3)
2-APB.
When human sperm monovalent CatSper currents were measured
by whole-cell patch-clamping, the I–V curve showed a virtual
absence of inward current, as described by Lishko et al. [11]
using the same recording conditions. 2-APB (5 μM) had no effect
on the large outward current (measured at + 55 mV; P > 0.4,
n = 6), but at 100 μM the current was inhibited by 43 +− 4%(P < 0.0002; n = 8; Figures 2a and 2b). We assessed the effect
of 2-APB on pHi using BCECF. Concentrations of 2-APB at 5,
15 and 50 μM increased pHi by 0.003 +− 0.002, 0.001 +− 0.004
and 0.004 +− 0.003 respectively (not significant, n = 3; Figures 2c
and 2d). In the absence of store mobilization, 2-APB dose-
independently activates a plasma membrane Ca2 + -permeable
channel in human sperm that is not CatSper. 2-APB, at doses from
2 to 100 μM, has been shown to activate Ca2 + influx and SOC
currents without mobilization of stored Ca2 + in cells expressing
Orai 3 (where a change in pore characteristics occurred) [24,25]
and also in cells co-expressing Orai with STIM2 [26].
2-APB enhances the progesterone-induced [Ca2+ ]i transient
The non-genomic action of progesterone on [Ca2 + ]i in human
sperm has a biphasic dose–effect relationship, apparently
reflecting effects at high- and low-affinity receptors [12,38].
Experiments were carried out using 3 μM progesterone because:
(i) this dose reflects concentrations in follicular fluid and the
cumulus oophorous [39]; and (ii) in our previous imaging and
fluorimetric studies, this concentration fully saturated the high-
affinity [Ca2 + ]i response but did not recruit a low-affinity receptor
response [40]. The latter is important, since exceeding the
Figure 3 2-APB modulates the progesterone-induced [Ca2+ ]i transient
(a) Elevation of [Ca2 + ]i at the PHN in response to stimulation with 3 μM progesterone
(arrow) under control conditions (left-hand panel) and after 200 s exposure to 5 μM 2-APB
(right-hand panel). Both experiments used cells from the same preparation. Traces show 6–8
representative single-cell responses and F mean (-) for all 107 (left-hand panel) and
125 (right-hand panel) cells in the experiment. (b) Summary of results from 20 pairs of
control and 5 μM 2-APB-pre-treated experiments. Each point shows the mean amplitude of the
progesterone-induced transient (increment in F mean) for all of the cells in a single experiment
(50–200 cells). Joined pairs of points show 5 μM 2-APB pre-treatment (right-hand point)
and corresponding control (left-hand point) using cells from the same ejaculate – such as
the pair shown in (a). Data from 20 pairs of experiments are shown and the overall mean for
all 20 is shown by -. (c) Effect of 5 μM 2-APB on amplitude distribution of single-cell
progesterone-induced transients. Grey bars show the control, black bars show the parallel
5 μM 2-APB-pre-treated experiment. (d) Dose-dependence of potentiation by 2-APB of the
progesterone-induced [Ca2 + ]i transient. Each bar shows the mean amplitude +− S.E.M. for
four sets of experiments (50–200 cells each). In each set, four experiments were carried out
with samples from the same ejaculate, using 0, 5, 50 or 100 μM 2-APB applied 200 s before
progesterone. Only 5 μM 2-APB significantly enhanced the [Ca2 + ]i transient. (e) Amplitude
of 2-APB-induced resting [Ca2 + ]i elevation (APB increment; x-axis) is not correlated with
the amplitude of subsequent progesterone-induced [Ca2 + ]i transient (progesterone increment;
y-axis). Results are from 197 cells in one experiment.
saturating dose will both minimize effects of any variation in the
concentration profile occurring during progesterone application
and reduce any effects of 2-APB on the affinity of progesterone for
its receptor. These effects could profoundly affect the responses
to sub-saturating concentrations of progesterone.
[Ca2 + ]i in PHN
In PHN, 3 μM progesterone induced a transient increase in
[Ca2 + ]i followed by a plateau in >90% of cells that was clearly
visible in the Fmean trace (Figure 3a, -) [41]. To test the
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effect of 2-APB on this response, experiments were carried out
in pairs, where cells from the same semen sample were exposed
to 3 μM progesterone with and without 2-APB pre-treatment.
In 17 out of 20 experiment pairs, pre-treatment with 5 μM 2-
APB (200 s) enhanced the amplitude of the progesterone-induced
increment in Fmean (pre-treated/control ratio = 1.58 +− 0.13,
n = 20; P = 0.0001, paired t test; Figures 3a and 3b). Population
(fluorimetric) recordings from fura-2-loaded cells confirmed this
observation, 2 μM 2-APB increasing the amplitude of the [Ca2 + ]i
transient from 137 +− 28 nM to 289 +− 42 nM (P = 0.0005; n = 14).
These effects occurred at doses >50× lower than the reported
IC50 values for inhibition of SERCAs or IP3Rs [31,32]. That this
potentiating action was not associated with the effects of 2-APB
on Ca2 + clearance mechanisms was confirmed by analysis of
the decay kinetics of progesterone-induced [Ca2 + ]i transients.
Inhibition of Ca2 + ATPases with bis-phenol (which does not
increase the progesterone transient amplitude in human sperm)
slows Ca2 + clearance, extending decay duration 2–3-fold [42,43].
In contrast, pre-treatment with 2-APB extended decay duration
(from Fmean peak to inflexion at the end of falling phase)
by only 11% (from 107 +− 7 s to 119 +− 7 s; P = 0.03; paired t
test, n = 16) and the absolute rate of decay was increased from
0.80 +− 0.09 to 1.16 +− 0.10% per second (P < 0.02; paired t test,
n = 16 experimental pairs), consistent with stimulation of Ca2 +
clearance at increased [Ca2 + ]i.
In eight experiment pairs where the effect of 5 μM pre-
treatment was large, we compared the amplitude distributions
of single-cell [Ca2 + ]i transients in control and 2-APB-pre-treated
cells. The distribution was bell-shaped under control conditions,
and in five out of the eight experiments, 5 μM 2-APB simply
shifted this distribution along the axis, only 5–10% of cells
generating [Ca2 + ]i transients of amplitude similar to the parallel
control (Figure 3c). In the three other experiments the 2-APB
pre-treatment resulted in a bi-modal or ‘smeared’ amplitude dis-
tribution (Supplementary Figure S2 at http://www.BiochemJ.org/
bj/448/bj4480189add.htm).
Pre-treatment with 50 μM or 100 μM 2-APB enhanced [Ca2 + ]i
transient amplitude in some experiments (Supplementary Figure
S3 at http://www.BiochemJ.org/bj/448/bj4480189add.htm and
Figure 3d), but this effect was not significant (P > 0.2; paired
t test, n = 4 sets of experiments). There was a clear difference in
dose-dependence between the effects of 2-APB on resting [Ca2 + ]i
and on progesterone-induced signalling (compare Figures 1b and
1c with Figure 3d).
The amplitude of the progesterone-induced [Ca2 + ]i signal
in human sperm is capacitation-dependent [44]. We therefore
investigated the effect of 5 μM 2-APB pre-treatment on
cells prepared in the absence of bicarbonate and BSA
(non-capacitating conditions). The [Ca2 + ]i transient in these
experiments was reduced compared with ‘capacitated’ cells
(Fmean = 37.6 +− 7.1%, n = 7 experiments and 59.6 +− 4.5%,
n = 20 experiments respectively; P < 0.025), but pre-treatment
with 5 μM 2-APB was still effective, enhancing transient
amplitude (82 +− 30%; P = 0.017; n = 7 experimental pairs;
paired t test), an effect similar to that in cells prepared in
capacitating medium (P = 0.39).
In experiments where 5 μM 2-APB pre-treatment caused
marked elevation of resting [Ca2 + ]i, we analysed the relationship
between this effect and the amplitude of the response (in the
same cell) to subsequent application of progesterone (‘e’ and
‘c’ in Supplementary Figure S1). There was no correlation
(Figure 3e; R = 0.10 +− 0.08; n = 10 experiments). 2-APB has
two discrete effects, potentiating progesterone-induced Ca2 +
influx at low micromolar doses and also increasing resting
Ca2 + influx.
[Ca2 + ]i responses in the flagellum
In OGB-loaded human sperm, fluorescence is most intense at
the PHN. This probably reflects the presence of the cytoplasmic
droplet in this region and it is likely that the signal from this region
also dominates fluorimetric population recordings. However, the
initial site of action of progesterone on human sperm is likely to be
CatSper channels in the principal piece of the flagellum [11,12].
We therefore compared the effects of 2-APB pre-treatment on
progesterone-stimulated [Ca2 + ]i responses in the PHN with those
in the flagellum.
Midpiece. In control experiments, application of progesterone
caused a transient rise in [Ca2 + ]i in the midpiece resembling
that occurring at the PHN. Kinetics of rise and decay of
Fmean were similar (P > 0.05; n = 11 pairs of experiments).
Transient amplitudes in the two regions were correlated (R = 0.74;
Supplementary Figure S4 at http://www.BiochemJ.org/bj/
448/bj4480189add.htm), but Fmean at the peak was ∼25%
smaller in the midpiece (P < 0.002; n = 11 pairs of experiments).
After pre-treatment with 5 μM 2-APB, this relationship
was maintained, but midpiece response amplitudes were
supplemented by the recruitment of an extra ‘late’ component
(Supplementary Figure S4; see below).
Principal piece. In five pairs of experiments (control and 5 μM
2-APB pre-treatment) we measured the progesterone-induced
[Ca2 + ]i signal in the anterior flagellar principal piece, using
only cells where this could be reliably assessed (visible and in
focus throughout experiment). Duration of the [Ca2 + ]i transient
in the principal piece was short, 74 +− 8 s compared with 143 +− 8 s
in the PHN of the same cells (P < 0.0005), but the amplitude
(normalized to pre-stimulus fluorescence) was significantly larger
(P = 0.0004; n = 43 cells; Figure 4a). 2-APB pre-treatment
enhanced the [Ca2 + ]i transient recorded at the PHN (compared
with controls), but at the principal piece we detected no effect of
2-APB (Figure 4b), such that the ratio of transient amplitude at the
PHN/transient amplitude at the principal piece (in the same cell)
increased from 0.8 +− 0.1 in control cells to 1.5 +− 0.2 in cells pre-
treated with 5 μM 2-APB (n = 43 and n = 57 cells respectively;
P = 0.00011; Figure 4c). We also assessed the effect of 2-
APB on progesterone-potentiated CatSper currents. As reported
previously [11,12], progesterone increased monovalent CatSper
currents, particularly enhancing inward current (Figure 4d). 2-
APB (5 μM) reduced CatSper current amplitude in four out
of four experiments, inhibiting inward and outward currents
by 21 +− 2% (P < 0.02) and 16 +− 6% (P = 0.12) respectively.
2-APB (100 μM) inhibited inward and outward currents by
68 +− 2% (P = 0.001) and 72 +− 3% (P = 00003) respectively(n = 6) (Figure 4d).
Thus 5 μM 2-APB enhances the progesterone-induced [Ca2 + ]i
transient in the PHN and midpiece but does not enhance CatSper-
mediated Ca2 + -influx. Surprisingly, although 100 μM 2-APB
significantly inhibited monovalent CatSper currents (Figures 2a,
2b and 4d), it failed to reduce the [Ca2 + ]i transient amplitude
(Figure 3d). One possible explanation is that high-dose 2-APB
potentiates Ca2 + influx similarly to 5 μM 2-APB [24,25,27,28]
and ‘compensates’ a smaller contribution from CatSper. In fact,
since the kinetics of the 2-APB-enhanced response closely
resemble those of the control response (mean time to peak
being identical; P = 0.5; n = 16 pairs of experiments), 2-APB-
sensitive channels may dominate the [Ca2 + ]i signal recorded at the
PHN.
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Figure 4 2-APB does not enhance the flagellar Ca2+ signal or potentiate
activation of CatSper by progesterone
(a) [Ca2 + ]i (OGB) signal from the PHN (white circles), midpiece (grey circles) and flagellum
(black circles) in response to application of 3 μM progesterone (arrow). Each trace shows
the mean response from the same nine cells. (b) Amplitude of progesterone-induced [Ca2 + ]i
transient at the PHN (left-hand panel) and midpiece (right-hand panel) under control conditions
(white bars; n = 43 cells) and after pre-treatment with 5 μM 2-APB (grey bars; n = 57 cells).
(c) Ratio of [Ca2 + ]i transient amplitudes simultaneously recorded from the PHN and flagellum
under control conditions (white bar; n = 43) and after pre-treatment with 5 μM 2-APB (grey
bar; n = 57). (d) Monovalent currents (DVF control) were enhanced by 500 nM progesterone
(upper black trace). Subsequent application of 5 μM 2-APB (upper grey trace) and 100 mM
2-APB (lower grey trace) reduced the amplitude of outward and inward currents.
Effects of 2-APB on the progesterone-induced sustained [Ca2+ ]i
elevation
Following the progesterone-induced [Ca2 + ]i transient, there is a
sustained elevation of [Ca2 + ]i above resting levels. To assess the
effect of 2-APB pretreatment on this [Ca2 + ]i plateau, we used
the value of Fmean recorded 4 min after progesterone application
(‘b’ and ‘d’ in Supplementary Figure S1). After 2-APB
pretreatment, sustained [Ca2 + ]i elevation at the PHN sometimes
exceeded that in the parallel control (Figure 3a), but this
effect was inconsistent and not significant (Fmean at 240
s: control = 19 +− 2%; 2-APB pre-treated = 20 +− 3%; P = 0.75;
paired t test; n = 19 pairs of experiments).
Recently, Park et al. [14] reported that progesterone-induced
sustained [Ca2 + ]i elevation was localized to the midpiece. In
11 of the experiment pairs (482 cells) we were able to analyse
[Ca2 + ]i at both the PHN and midpiece. As described above,
the sustained [Ca2 + ]i response (Fmean 240 s after progesterone
application) at the PHN showed no effect of pretreatment with
5 μM 2-APB (control = 18 +− 5%; 2-APB = 20 +− 6%; P = 0.66;
n = 11 experiment pairs). However, in the same cells, the
sustained increase in fluorescence at the midpiece was enhanced
>3-fold, from 16 +− 4% (control) to 52 +− 12% (2-APB pre-
treated; P = 0.002; n = 11 experiment pairs; Figures 5a–5c).
The amplitude distribution of these 2-APB-enhanced sustained
midpiece responses was bimodal (Figures 5b and 5d). When
cells were pre-treated with 100 μM 2-APB, Fmean recorded at
the midpiece 240 s after progesterone was significantly smaller
than in parallel controls (P < 0.05, n = 6 experimental pairs;
P < 0.005; Figure 5c).
Late activation of the midpiece sustained responses
The rising phase of the progesterone-induced [Ca2 + ]i increase
in the midpiece of 2-APB-pre-treated cells often showed an
inflexion, apparently reflecting a second ‘delayed’ rise in
fluorescence occurring 20–30 s after stimulation (Figure 5e, black
trace; arrowhead). In six pairs of experiments where the midpieces
were well-immobilized we assessed the occurrence of this ‘late’
response. Approximately one-third of 5 μM 2-APB pre-treated
cells (34 +− 6%; 424 cells in six experiments) showed a clear
inflexion, but this pattern of response was rare in parallel controls
(7.6 +− 2.8%; n = 443 cells in six experiments; P = 0.01; paired
t test). This ‘late’ rise in fluorescence at the midpiece was
always followed by a large (>80% at 240 s; see Figure 5d)
sustained increase in midpiece fluorescence. Association of these
two events was highly non-random (P = 10− 10; χ 2 test). Thus
it appears that the large type of sustained responses observed
in the midpiece activates during the rising phase of the [Ca2 + ]i
transient, adding a ‘step’ to the signal. In three experiments we
followed the kinetics of the response to progesterone in more
detail by using an increased camera frame rate (10 Hz). Consistent
with recent reports that progesterone directly activates CatSper
channels [11,12], the [Ca2 + ]i response in the anterior principal
piece preceded that in the PHN region by 1.6 +− 0.2 s (n = 29
cells; P < 10− 8) (Figure 5f). A similar spatio-temporal pattern
has recently been reported upon photolysis of caged progesterone
[45]. When a sustained [Ca2 + ]i increase occurred in the midpiece
there was often a clear inflexion in the rising phase after 10–
30 s (Figures 5f and 5g; Supplementary Movies S1 and S2 at
http://www.BiochemJ.org/bj/448/bj4480189add.htm).
The sperm midpiece contains the sperm’s mitochondria. Since
the large 2-APB-potentiated sustained response is localized here
and occurs 20–30 s after initiation of the [Ca2 + ]i transient,
it is likely that it includes a contribution from OGB within
the mitochondrial matrix compartment, which will fluoresce
upon mitochondrial Ca2 + accumulation. Imaging data do not
allow us to distinguish confidently between mitochondrial Ca2 +
accumulation and a discrete ‘late’ Ca2 + influx at the midpiece,
but it may be significant that 5 μM 2-APB is reported to slow
the export of Ca2 + from mitochondria [46]. Since Ca2 + uptake
by mitochondria is by a low-affinity transporter [47], if this late
response reflects mitochondrial Ca2 + accumulation it reveals a
large increase in [Ca2 + ]i in the midpiece of these sperm.
Application of 2-APB during the sustained component of the
progesterone-induced [Ca2 + ]i increase
To investigate further the effects of 2-APB on the sustained
[Ca2 + ]i increase, we applied the drug 6–7 min after progesterone
stimulation, following completion of the [Ca2 + ]i transient. 2-APB
at 5 μM caused a reversible tonic increase in fluorescence at the
PHN (21 +− 6% increase in Fmean at 4 min after application, four
experiments; Figure 6a). The midpiece did not show the large
sustained response that occurred when 2-APB was applied prior to
progesterone. When 50 μM 2-APB was applied in this way there
was an immediate but transient fall in [Ca2 + ]i. The [Ca2 + ]i plateau
(‘b’ in Supplementary Figure S1) was reduced by 62 +− 13%
c© The Authors Journal compilation c© 2012 Biochemical Society© 2012 The Author(s)
The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
Progesterone and Ca2 + signalling in sperm 195
Figure 5 2-APB (5 μM) enhances sustained elevation of [Ca2+ ]i in the
midpiece
(a and b) Progesterone-induced responses at the midpiece under control conditions (a) and
after application of 5 μM 2-APB (first arrow; b). Each plot shows six to nine representative
single-cell traces and F mean (-) for all 25 (a) and 31 (b) cells in the experiment.
(c) Dose-dependence of the effect of 2-APB pre-treatment on the sustained [Ca2 + ]i signal.
The amplitude of the sustained response (240 s after progesterone addition) in PHN (left-hand
bars) and midpiece (right-hand bars) after exposure to 5 μM 2-APB (light grey bars) and
100 μM 2-APB (dark grey bars) was normalized to the amplitude of the parallel control
(shown by a broken line). Each bar shows the means +− S.E.M. of 11 (5 μM 2-APB) and six
(100 μM 2-APB) experiments. *P < 0.05; **P < 0.005 compared with control. (d) Amplitude
distribution of single-cell sustained [Ca2 + ]i increases (240 s after progesterone addition). Open
circles (-) show responses of 2-APB pre-treated cells (136 cells from five experiments),
closed circles (-) show responses from 135 cells in the five parallel control experiments.
(e) Progesterone-stimulated [Ca2 + ]i elevation in the PHN (grey trace) and midpiece (black
trace) of a 5 μM 2-APB pre-treated cell. 2-APB was added at the first arrow, 3 μM progesterone
at the second arrow. An inflection in the rising phase of the midpiece trace occurs ∼20 s
after application of progesterone (arrowhead). (f) Progesterone-stimulated [Ca2 + ]i elevation
in the anterior flagellum (dark grey), PHN (light grey) and midpiece (black) of a 5 μM 2-APB
pre-treated cell imaged at 10 Hz. Progesterone was applied at 7 s (arrow). The anterior flagellar
response precedes responses in the other two compartments and the rising phase of the
midpiece response shows an inflexion ∼25 s after onset. (g) Image series of the same cell
as (f), showing the delayed [Ca2 + ]i rise in the midpiece. Numbers show time in seconds.
Progesterone was applied at 7 s.
(P < 0.02; nine experiments). [Ca2 + ]i oscillations (when present)
slowed or stopped for 2–3 min (Figure 6b). [Ca2 + ]i then recovered
to levels slightly above those seen before application of the
Figure 6 2-APB modifies the sustained [Ca2+ ]i elevation
(a) 2-APB (5 μM) was applied to cells already stimulated with 3 μM progesterone (prog).
2-APB caused a tonic increase in [Ca2 + ]i that reversed upon washout (↑) of the drug. Traces
show PHN responses from seven individual representative cells. (b) 2-APB (50 μM) was applied
to cells already stimulated with 3 μM progesterone. Upon application of the drug, [Ca2 + ]i fell
and oscillations were suppressed, but [Ca2 + ]i then recovered despite the continued presence
of the drug. Traces show PHN responses from six individual representative cells.
drug (increment in Fmean 4 min after 2-APB = 5 +− 2%; nine
experiments, P < 0.05; Figure 6b). 2-APB at 100 μM had a similar
effect.
In summary, although the progesterone-induced [Ca2 + ]i signal
was detectable first in the flagellum, where CatSper is present,
pretreatment with 2–5 μM 2-APB ‘amplified’ the progesterone-
induced [Ca2 + ]i transient of human sperm at the PHN and
midpiece by enhancing activation of a Ca2 + -permeable channel
that is not CatSper. Pretreatment with high doses of 2-APB (50–
100 μM) failed to potentiate the transient and had an inhibitory
effect on the sustained [Ca2 + ]i increase. Intriguingly, when
applied during the [Ca2 + ]i plateau, high doses of 2-APB exerted a
strong but transient inhibitory action, which was not evident when
applied prior to stimulation with progesterone. If 2-APB-sensitive
channels contribute to sustained Ca2 + influx, inhibition of CatSper
by 2-APB (Figure 4d) might release the 2-APB-sensitive channels
from inhibitory regulation by [Ca2 + ]i, leading to recovery of the
Ca2 + influx.
Orai and STIM proteins are expressed in human sperm
2-APB modulates interaction of STIM with store-operated
channel subunits (Orai and possibly TRPC) in the plasma
membrane. To investigate STIM and Orai expression in human
sperm, we used anti-Orai and anti-STIM antibodies to probe
Western blots and to perform immunofluorescent staining.
STIM1
In Western blots, the anti-STIM1 (ProSci catalogue number 4119
and BD Biosciences catalogue number 610954) antibody gave
very weak bands. However, after immunoprecipitation with the
BD Biosciences antibody, we obtained a strong band at ∼95 kDa
(Figure 7a), consistent with reports that glycosylation causes
the protein to migrate with an apparent mass 90 kDa rather
than the predicted 77 kDa [48]. Immunoprecipitation with the
Sigma antibody gave a less intense band (results not shown).
The positive control [STIM1–GFP (green fluorescent protein)
transfected HEK (human embryonic kidney)-293 cells] gave a
clear band at ∼110 kDa, reflecting the presence of the 25 kDa
GFP tag (Figure 7a).
Immunofluorescent staining with the ProSci antibody gave
a bright spot at the sperm neck region and also stained the
midpiece, which often appeared as two parallel streaks. Antibody
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Figure 7 Expression of Orai and STIM in human sperm
(a) STIM1. Left-hand panels: Western blot for STIM1 (ProSci 4119); lane 1: human sperm proteins purified by immunoprecipitation with an anti-STIM1 antibody. A band is seen at ∼95 kDa and
also at 55–60 kDa due to the presence of anti-STIM1 antibody from the immunoprecipitation procedure. Lane 2 is protein from STIM1–GFP-transfected HEK-293 cells. STIM1 appears at ∼110 kDa
due to the presence of the 25 kDa GFP tag. Separation of images in this and other gels indicates that lanes were not originally directly adjacent. Right-hand panels: immunofluorescent staining with
anti-STIM1 antibody (ProSci). Upper panels show STIM1 staining and the corresponding phase image. Fluorescence occurs over the midpiece with a bright spot at the sperm neck (arrows). Lower
panels show cells incubated with antibody pre-adsorbed with the antigenic peptide, which abolished staining. (b) STIM2. Left-hand panels: Western blot for STIM2 (ProSci antibody 4123); lane 1:
human sperm proteins. An intense doublet is present at 85–90 kDa. Lane 2: as lane 1, but antibody was pre-adsorbed with the antigenic peptide. Right-hand panels: immunofluorescent staining
with anti-STIM2 antibody. The upper panels show STIM2 staining and corresponding phase image. Staining occurs over the flagellum, being heaviest at the midpiece (white arrows). In a minority of
cells (<10 %), we observed staining over the acrosome (yellow arrow). The lower panels show cells incubated with antibody pre-adsorbed with the antigenic peptide, which abolished flagellar and
acrosomal staining but resulted in fluorescence just behind the equatorial segment (blue arrows). (c) Orai 1. Left-hand panels: Orai 1 immunoblot (Sigma antibody O8264); lane 1: human sperm
proteins. Lane 2: proteins extracted from Myc-tagged Orai 1-transfected HEK-293 cells. Deduced molecular mass of non-glycosylated Orai 1 is ∼35 kDa. Right-hand panel: immunofluorescent
staining with anti-Orai 1 antibody. Upper panels show Orai 1 staining (Sigma antibody O8264) and corresponding phase image. Staining occurs primarily over the acrosome and midpiece and weakly
on the principal piece. Lower panels show cells stained similarly but omitting the primary antibody. (d) Orai 2. Left-hand panels: Western blot for Orai 2 (ProSci antibody 4111); lane 1: human sperm
proteins. Lane 2: as lane 1, but antibody pre-adsorbed with the antigenic peptide. Right-hand panel: immunofluorescent staining with anti-Orai 2 antibody. Upper panels show Orai 2 staining and
corresponding phase image. Staining occurs over the midpiece (white arrows) and acrosome (yellow arrows), with weaker staining over the principal piece. Lower panels show cells incubated with
antibody pre-adsorbed with the antigenic peptide, which reduces/abolishes staining of the acrosome, midpiece and flagellum, but resulted in fluorescence just behind the equatorial segment (blue
arrows). (e) Orai 3. Left-hand panels: Western blot for Orai 3 (ProSci antibody 4215). Lane 1: human sperm proteins. Lane 2: as lane 1, but antibody was pre-adsorbed with the antigenic peptide,
which did not block band detection. Right-hand panels: immunofluorescent staining with anti-Orai 3 antibody. Upper panels show Orai 3-staining and corresponding phase image. Staining occurs
primarily over the anterior midpiece and sperm neck (arrows). Lower panels show cells incubated with antibody pre-adsorbed with the antigenic peptide, which abolished staining. (f) Diagrammatic
representation of ‘typical’ localization (immunofluorescence pattern) for each of the proteins investigated.
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pre-adsorbtion with the blocking peptide abolished this staining
(Figure 7a). Similar localization of STIM1 in human sperm was
observed using a different antibody [14].
STIM2
The anti-STIM2 (ProSci catalogue number 4123) antibody
gave an intense doublet at 85–90 kDa and a weak band at
≈45 kDa. Pre-adsorption with the blocking peptide abolished
this staining (Figure 7b). Immunofluorescent staining occurred
on the flagellum, particularly the midpiece. In <10% of cells
we also saw staining over the acrosome (Figure 7b). Antibody
pre-adsorption with the blocking peptide completely blocked this
staining, but we observed some fluorescence at the equatorial
segment that was not seen with unblocked antibody (Figure 7b).
The strong STIM2 doublet in the Western blot is consistent with
expression of both STIM2 and pre-STIM2 which is cytoplasmic
[49], which may explain the surprising finding of staining by
anti-STIM2 in the principal piece, where there are no intracellular
membranous organelles reported.
Orai 1
In Western blots, anti-Orai 1 (Sigma catalogue number O8264
or ProSci catalogue number 4041) antibody gave a clear band
at ∼35 kDa, the predicted mass for the unglycosylated form of
the protein. Protein from HEK-293 cells expressing recombinant
Myc-tagged Orai 1 (positive control) gave heavy staining between
35 and 50 kDa (Figure 7c), probably reflecting glycosylation
[50]. Immunofluorescent staining (Sigma antibody) showed
fluorescence over the acrosome and midpiece and weak signal
from the principal piece of the flagellum (Figure 7c). Controls
without primary antibody gave no significant fluorescence.
Orai 2
Anti-Orai 2 (ProSci catalogue number 4111) gave a strong band
of ∼36 kDa in Western blots. The predicted mass is ∼29 kDa,
but glycosylation is known to cause Orai migration at higher
than predicted molecular mass on SDS/PAGE. Pre-adsorption
with the blocking peptide specifically abolished staining of this
band (Figure 7d). Immunostaining gave fluorescence over the
midpiece and principal piece that was inhibited by pre-adsorption
with blocking peptide but, as with STIM2, some staining of
the equatorial segment occurred which was not apparent with
unblocked antibody (Figure 7d). Controls with no primary
antibody gave no fluorescent signal (results not shown).
Orai 3
Western blotting of sperm lysate with anti-Orai 3 (ProSci
catalogue number 4215) gave several bands, including one at the
predicted mass of ∼36 kDa. Pre-adsorption with the blocking
peptide had no effect. Immunofluorescence with the same
antibody showed staining primarily over the anterior midpiece
and neck that was abolished by pre-adsorption with the blocking
peptide (Figure 7e). Owing to the ambiguous nature of these data,
we attempted to detect Orai3 by MS but were not able to do so.
Proteins of low abundance that are known to be present in sperm
can be difficult to detect by this approach, only ∼1000 proteins
have been identified so far out of an estimated 2500–3000 in
human sperm [51].
TRPV3 (transient receptor potential vanilloid 3)
2-APB at concentrations <10 μM enhances activity of STIM–
Orai. The only non-Orai channel type known to be activated
by such doses of 2-APB is TRPV3 [52]. Western blotting
of human keratinocyte proteins (positive control) for TRPV3
gave a band of the appropriate molecular mass. TRPV3 could
not be detected in human sperm (Supplementary Figure S5 at
http://www.BiochemJ.org/bj/448/bj4480189add.htm).
Ca2 + store mobilization and distribution of STIM proteins
In somatic cells, Ca2 + store mobilization causes redistribution
of STIM1 to regions of the endoplasmic reticulum close to the
plasmalemma, forming distinct puncta [53]. We used 15 μM bis-
phenol, which inhibits both SERCA and the secretory pathway
Ca2 + -ATPase [42] to activate sperm CCE and investigated the
effect on distribution of STIM1. Bis-phenol caused sustained
[Ca2 + ]i elevation within 4 min (Fmean = 48.7 +− 3.4%; n = 17;
Supplementary Figure S6a at http://www.BiochemJ.org/bj/
448/bj4480189add.htm), an effect that was abolished in EGTA-
buffered saline ([Ca2 + ]≈3 × 10− 7 M). Application of Ca2 +
(1.8 mM) to cells treated with bis-phenol in Ca2 + -free conditions
caused a large sustained [Ca2 + ]i elevation, consistent with
activation of CCE (Supplementary Figure S6b). We exposed
sperm to 15 μM bis-phenol (12 min) in sEBSS, stained for STIM1
and assessed fluorescence in the midpiece as a percentage of the
total. In control cells, 60–70% of total fluorescence was present
in the neck/midpiece (Supplementary Figure S6c). Exposure to
bis-phenol caused no change (P > 0.05; three experiments, 170
cells).
The localization of STIM and Orai primarily to the neck,
midpiece and acrosomal regions (Figure 7f) coincides with the
locations of Ca2 + stores in mammalian sperm [54,55]. TRPC
proteins in sperm are also present in these regions [56] and may
combine with Orai to form store-regulated or receptor-operated
channels [18]. Low concentrations of 2-APB facilitate STIM–Orai
interaction [21–23] and the 2-APB-enhanced [Ca2 + ]i signalling
described above is localized to the PHN. We propose that 2–
5 μM 2-APB enhances progesterone-induced Ca2 + influx by
modulating the activation by STIM of channels incorporating
Orai. The presence of STIM2, pre-STIM2 and (potentially) Orai
3 may explain the ability of 2-APB to induce Ca2 + influx in the
absence of progesterone stimulation and even at doses 50 μM.
The mechanism by which progesterone activates these 2-APB-
sensitive channels is not yet established. Although activation of
Ca2 + influx by treatments that mobilize stored Ca2 + has been
reported on numerous occasions [54] (Supplementary Figure
S6b), we were not able to detect conventional CCE currents in
human sperm held under conventional whole-cell clamp (results
not shown).
Effects of loperamide on progesterone-induced [Ca2+ ]i and sperm
motility
Loperamide (3–30 μM) is an agonist of SOCs, increasing the
Ca2 + influx upon store depletion [57]. Loperamide at 10 μM
increased resting [Ca2 + ]i in 66 +− 7% of cells (n = 8 experiments;
Figure 8a). The Fmean 90 s after application of loperamide was
24 +− 4%, increasing to 31 +− 7% after 3 min (n = 8). Superfusion
with EGTA-buffered saline (∼3 × 10− 7 M) for 3 min prior
to loperamide application abolished this effect (results not
shown). The cytoplasmic alkalinizing effect of 10 μM loperamide
was negligible (0.013 +− 0.005 units; n = 3). Inward monovalent
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Figure 8 Loperamide potentiates the response of human sperm to
progesterone
(a) Pre-treatment with 10 μM loperamide (arrow) followed by application of 3 μM progesterone
(shading). Traces show nine representative single-cell PHN responses and F mean (-)
for all 81 cells in the experiment. Loperamide elevates resting [Ca2 + ]i and subsequent
exposure to progesterone induced an initial [Ca2 + ]i transient followed by large [Ca2 + ]i
oscillations. (b) Duration of the progesterone-induced [Ca2 + ]i transient in the PHN was
increased by loperamide pre-treatment. Bars show means +− S.E.M. for 11 paired experiments.
(c) Progesterone-induced sustained [Ca2 + ]i increase (F mean at 240 s after progesterone) was
enhanced by loperamide pre-treatment. Bars show means +− S.E.M. for nine paired experiments.
(d) Mean normalized fluorescence (F mean) in the PHN (-) and in the midpiece (-) under
control conditions (upper panel; mean of 19 cells) and after pre-treatment with 10 μM loperamide
(lower panel; mean of 33 cells). Potentiation by loperamide of [Ca2 + ]i transient duration and
sustained [Ca2 + ]i elevation are similar in the two compartments. (e) Loperamide enhances
progesterone-induced hyperactivation. Each bar shows the percentage of hyperactivated cells
(means +− S.E.M.; n = 7). Progesterone (3 μM) and loperamide (10 μM), applied individually,
failed significantly to increase hyperactivation (not significant; NS). When cells were pre-treated
with loperamide (3 min), progesterone significantly increased the proportion of hyperactivated
cells over all the other conditions (*P < 0.02).
CatSper currents were insensitive to loperamide and outward
currents were semi-reversibly inhibited (Supplementary Figure
S7 at http://www.BiochemJ.org/bj/448/bj4480189add.htm).
Effects of 10 μM loperamide on the amplitude of
the progesterone-induced [Ca2 + ]i transient were inconsistent
(P = 0.38, paired t test). However, duration of the progesterone-
induced [Ca2 + ]i transient (Fmean initiation to end of falling
phase) was significantly increased, from 150 +− 8 to 284 +− 30 s(P = 0.00035; paired t test; n = 11; Figure 8b). In 10–20% of
cells, the transient peak persisted for 50–100 s and the [Ca2 + ]i
transient was often followed by a second large plateau or a series
of [Ca2 + ]i oscillations (Figure 8a). Similarly to pre-treatment
with 5 μM 2-APB, an inflexion occurred in the rising phase of
the midpiece response in >20% of cells, indicating activation
of the late sustained component of the response. Sustained
[Ca2 + ]i elevation (Fmean 240 s after progesterone) was enhanced
(P < 0.05; paired t test; n = 9) at both the PHN and midpiece
(Figures 8c and 8d).
Application of progesterone to free swimming sperm, by
mixing or uncaging, induces a burst of transitional or
hyperactivated motility, probably associated with the consequent
Ca2 + transient [58,59], but this rapidly decays, such that effects
recorded by CASA are small. Since loperamide pre-treatment
both prolongs the [Ca2 + ]i transient and enhances the sustained
phase, we investigated the effects of loperamide on progesterone-
induced hyperactivation. Progesterone (3 μM) alone increased the
proportion of cells classified as hyperactivated from 4.2 +− 1.0 tojust 7.8 +− 1.5 (P < 0.01) and 10 μM loperamide had no significant
effect (P > 0.05; paired t test, n = 7 experiments; Figure 8e).
However, when cells were exposed to loperamide for 200 s, then
progesterone was applied before introduction into the chamber,
the proportion of hyperactivated cells increased to 17.5 +− 2.2%,
significantly greater than progesterone or loperamide exposure
alone (Figure 8e; P = 0.02; paired t test, n = 7 experiments).
The loperamide-enhanced sustained [Ca2 + ]i signal powerfully
modifies motility in human sperm.
Effective progesterone-induced [Ca2 + ]i signalling is character-
istic of fertile human sperm [9,10]. Our understanding of this non-
genomic action of progesterone has recently been transformed by
the discovery that CatSper channels in the flagellum of patch-
clamped human sperm are activated by this steroid. We have
shown in the present study that Ca2 + -permeable channels at the
sperm neck region, sensitive to 2-APB and loperamide, amplify
and prolong progesterone-induced Ca2 + signals initiated in the
anterior flagellum. Subcellular localization of the Ca2 + signal,
patch-clamp measurements of CatSper currents and assessment
of pHi confirm that these effects are not by direct or indirect
activation of CatSper channels and occur under conditions where
CatSper may be partially inhibited. STIM and Orai proteins,
which are sensitive to and can be directly activated by low doses
of 2-APB, are localized primarily at the sperm neck. We propose
that 2-APB-sensitive channels at the sperm neck (probably STIM-
regulated Orai or TRPCs) are essential for human sperm Ca2 +
signalling activated through CatSper, providing amplification,
spatio-temporal complexity and flexibility to the sperm Ca2 + -
signalling toolkit. Release of stored Ca2 + and CCE may underly
this propagation from the flagellum into the sperm neck region,
but we were unable to detect conventional CCE currents in human
sperm, so the mechanism of activation of these channels remains
an open question.
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Figure S1 Diagrammatic illustration showing quantified components of [Ca2+ ]i traces in control experiments (left) and after pre-treatment with 2-APB (right)
‘a’ and ‘b’ show transient and sustained response amplitudes under control conditions. ‘c’ and ‘d’ show transient and sustained response amplitudes in 2-APB and loperamide experiments. ‘e’ shows
the amplitude of response to 2-APB or loperamide.
Figure S2 Amplitude distribution for single-cell progesterone transients recorded at the PHN from two pairs of experiments
In each graph, blue bars show the amplitude distribution for the control experiment and red bars show the distribution for a parallel experiment where cells were pre-treated with 5 μM 2-APB. In
experiment (a), most cells show a large shift to the right after 2-APB pre-treatment but approximately 10 % are clustered at amplitudes similar to the control mean. In experiment (b), 2-APB increases
the transient amplitude in only a subset of cells, the distribution peak remaining at a F of ∼70 %.
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Figure S3 Dose-dependence of effect of pre-treatment with 2-APB on the [Ca2+ ]i transient induced by 3 μM progesterone
2-APB (except controls) was added at the first arrow, progesterone (3 μM) was added at the second arrow. (a) Black circles, vehicle control; white circles, 5 μM 2-APB; grey circles, 50 μM 2-APB.
(b) Black circles, vehicle control; white circles, 5 μM 2-APB; grey circles, 100 μM 2-APB.
Figure S4 Relationship between the amplitude of the progesterone-
induced [Ca2+ ]i transient recorded at the PHN (x axis) and midpiece
(y axis)
Under control conditions (black circles), midpiece amplitude is typically ∼75 % of amplitude at
PHN (y = 0.75×− 3.8). In 5 μM 2-APB-pretreated cells (red circles), both PHN and midpiece
transients are larger but also the line of best fit is ‘shifted’ upward due to recruitment of an extra
midpiece component in a sub-population of cells (y = 0.67×51). The results are from five pairs
of experiments; each data set shows >130 cells.
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Figure S5 TRPV3 is not detectable in human sperm
(a) The left-hand panel shows the immunoblot for TRPV3 with sperm preparations from two different donors (d1 and d2). The final lane shows the positive control (human keratinocyte proteins;
skin). The arrow on lane 5 shows the strong band corresponding to the predicted mass for TRPV3. The right-hand panel shows an identical blot, carried out in parallel, after pre-adsorbing the TRPV3
antibody with the antigenic peptide. The band detected in the positive control has been lost. (b) As for (a), but using four further donors (d3–d6).
Figure S6 Activation of SOCs does not cause redistribution of STIM1
(a) Bis-phenol (15 μM), an inhibitor of Ca2 + -store ATPases, causes a sustained increase in
[Ca2 + ]i . Six representative single-cell responses and the means for all cells in the experiment
(circles) are shown. (b) In EGTA-buffered saline, bis-phenol fails to significantly increase
[Ca2 + ]i , but upon reintroduction of 1.8 mM Ca2 + , a large prolonged [Ca2 + ]i elevation was
seen, indicating the activation of SOCs by store depletion. (c) Intensity of immunofluorescent
staining of STIM1 in the sperm midpiece (as a proportion of total fluorescence of the sperm)
under control conditions (white bar) and after incubation for 12 min in the presence of 15 μM
bis-phenol (grey bar). Each bar shows the mean +− S.E.M. of fluorescence in 170 cells from
three experiments.
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Figure S7 Loperamide does not enhance currents through CatSper
channels
(a) Currents in a whole-cell clamped sperm induced by a 1 s voltage ramp from − 80 mV
to + 80 mV. Black trace shows current in HS medium with 2 mM Ca2 + [1]. Blue trace
shows current in DVF (divalent cation-free) medium. Red trace shows current in the presence of
10 μM loperamide. (b) Time-course of inhibition by 10 μM loperamide of outward conductance
(normalized to maximum). Filled squares show control experiments where conductance is
reversibly enhanced in DVF medium (shading). Open squares show the effect of 10 μM
loperamide (red bar). Each line shows the mean of four experiments +− S.E.M. Conductance was
calculated using δI/δV at 70–80 mV.
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